SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo)
DEPO 7.300+1.7%Aug 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BD who wrote (811)5/11/1998 8:18:00 PM
From: StockDoc  Read Replies (1) of 887
 
I don't know about the "well connected" consulting firm but I know something about FDA. In this case, I would not count on "connections". The guy who heads the division and that handles the "case" at the FDA (Temple) is famous for his consistent, impartial and scientific approach to NDAs. In fact, he's developing FDA's strict and pretty clear guidelines for NDA processes. I doubt that even the Pope could pressure him into anything (e.g., Depocyt approval) that does not meet the minimal requirements. Other drugs might better work out for them (under conditions mentioned before), if they can get money. I wish them well.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News